Morgan Burke
Gerontology · Birmingham, ALNPI 1063815082
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Coloplast accounts for 72.0% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $2,877, more than ten times the $20 reported in 2021.
Across 64 payments — averaging $79.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$4K
- Axonics, Inc.$934
- Endo Pharmaceuticals Inc.$130
- Sumitomo Pharma America, Inc.$114
- Antares Pharma, Inc.$50
- Urogen Pharma, Inc.$46
- plus $149 from 7 others
What the payments were for
- Consulting fees$1,65032%
- Travel & lodging$85317%
- Food & beverage$2,57551%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 25 | $3,655 |
| Axonics, Inc. | 17 | $934 |
| Endo Pharmaceuticals Inc. | 6 | $130 |
| Sumitomo Pharma America, Inc. | 6 | $114 |
| Antares Pharma, Inc. | 1 | $50 |
| Urogen Pharma, Inc. | 1 | $46 |
| Boston Scientific | 2 | $41 |
| Cycle Pharmaceuticals Inc | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Photocure Inc | 1 | $20 |
| Urovant Sciences Inc | 1 | $19 |
| Hollister Incorporated | 1 | $13 |
| ABC Home Medical Supply, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Luja Coude$1,650
- TITAN$1,402
- Axonics$474
- Bulkamid$121
How this compares
$5,078 in reported general payments places this provider in the 85th percentile of 143 gerontology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 112 | $71,784 |
| MyrbetriqMirabegron | 123 | $64,218 |
| Estradiol | 44 | $3,568 |
| Trospium Chloride ErTrospium Chloride | 28 | $3,461 |
| Oxybutynin Chloride ErOxybutynin Chloride | 123 | $2,976 |
| Tamsulosin Hcl | 130 | $1,796 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 67 | $1,355 |
| Methenamine Hippurate | 54 | $1,310 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 90 | $1,266 |
| Solifenacin Succinate | 22 | $656 |
| Trospium Chloride | 11 | $479 |
| NitrofurantoinNitrofurantoin Macrocrystal | 13 | $400 |
| Oxybutynin Chloride | 29 | $294 |
| Ciprofloxacin Hcl | 42 | $238 |
| Dutasteride | 13 | $232 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $114 | $71,784112 claims |
| Astellas Pharma US IncMyrbetriq | $21 | $64,218123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 143 gerontology providers in Alabama.
Other gerontology in Birmingham
- Esther LangeBirmingham$10K
- Melissa HornBirmingham$7K
- Rachel HawesBirmingham$7K
- Whitney GrayBirmingham$6K
- Robin AbelBirmingham$3K
- Anna EvattBirmingham$2K
- Sonya FlanaganBirmingham$2K
- Hua LinBirmingham$2K
- Teresa CooperBirmingham$1K
- Ryan ShannonMontgomery$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.